Skip to content
NewsBlazeIN – Lifestyle
Author:
Tensive
Tensive reports pivotal 12-month clinical trial data confirming REGENERA™ delivers natural breast reconstruction after lumpectomy
July 28, 2026
Tensive appoints Peter Crosby Chairman as its bioresorbable breast reconstruction scaffold approaches regulatory approval
July 8, 2026